Markets:

Overview

News

Currencies

International

Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

180.96 -21.58 (-10.65%)

Official Closing Price Updated: 7:00 PM EST, Feb 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗

Today 13:05 EST

Via Chartmill

IQVIA (IQV) Q4 2025 Earnings Call Transcript ↗

Today 13:02 EST

IQVIA (IQV) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

IQVIA (IQV) Stock Trades Down, Here Is Why

Today 11:55 EST

Shares of clinical research company IQVIA (NYSE: IQV) fell 8.5% in the morning session after the company issued a weak full-year 2026 profit forecast that fell below Wall Street expectations.

Via StockStory

What's going on in today's session: S&P500 gap up and gap down stocks ↗

Today 10:35 EST

Via Chartmill

IQVIA Holdings Inc (NYSE:IQV) Beats Q4 Revenue Estimates and Issues 2026 Guidance ↗

Today 8:32 EST

Via Chartmill

IQVIA’s (NYSE:IQV) Q4 CY2025 Sales Top Estimates

Today 7:36 EST

Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue...

Via StockStory

IQVIA (IQV) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 03, 2026

Clinical research company IQVIA (NYSE: IQV) will be reporting results this Thursday before market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

FDA Codifies AI’s Role in Drug Production: New 2026 Guidelines Set Global Standard for Pharma Safety and Efficiency

January 28, 2026

In a landmark shift for the biotechnology and pharmaceutical industries, the U.S. Food and Drug Administration (FDA) has officially entered what experts call the “Enforcement Era” of artificial...

Via TokenRing AI

Topics Artificial Intelligence Economy

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors ↗

January 25, 2026

Via MarketBeat

2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down

January 12, 2026

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

Topics Credit Cards

3 Inflated Stocks with Open Questions

January 11, 2026

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Via StockStory

3 Reasons to Sell IQV and 1 Stock to Buy Instead

January 11, 2026

What a time it’s been for IQVIA. In the past six months alone, the company’s stock price has increased by a massive 51.4%, reaching $242.50 per share. This performance may have investors wondering how...

Via StockStory

1 S&P 500 Stock to Consider Right Now and 2 We Turn Down

January 07, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

1 Profitable Stock to Target This Week and 2 Facing Challenges

January 06, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Backbone of Discovery: A Deep Dive into Charles River Laboratories (CRL)

December 23, 2025

In the complex ecosystem of modern medicine, few companies carry as much institutional weight—or stir as much controversy—as Charles River Laboratories International, Inc. (NYSE: CRL). As of December...

Via PredictStreet

Topics Animal Testing Artificial Intelligence Economy

Navigating the Labyrinth: Why Trust, Training, and Data are Paramount for Healthcare AI’s Future

December 12, 2025

Artificial Intelligence (AI) stands at the precipice of revolutionizing healthcare, promising breakthroughs in diagnostics, personalized treatment, and operational efficiency. However, the path to...

Via TokenRing AI

Topics Artificial Intelligence

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗

December 04, 2025

Let's have a look at the S&P500 stocks with an unusual volume in today's session.

Via Chartmill

Gapping S&P500 stocks in Thursday's session ↗

December 04, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Merit Medical Systems, Globus Medical, Tenet Healthcare, Progyny, and IQVIA Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

3 Profitable Stocks We Steer Clear Of

November 17, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia ↗

November 17, 2025

Goldman Sachs says investors are shifting toward companies quietly using AI to cut costs and drive productivity-led growth.

Via Benzinga

Topics Artificial Intelligence

Market Holds Breath as Nvidia Earnings and Jobs Report Loom, Shaping AI's Future and Economic Direction

November 17, 2025

As of November 17, 2025, U.S. financial markets are navigating a period of palpable anticipation and caution, with the Dow Jones Industrial Average (DJIA), Nasdaq Composite (NASDAQ), and S&P 500 (SPX)...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

2 S&P 500 Stocks with Solid Fundamentals and 1 Facing Challenges

November 16, 2025

Via StockStory

Topics Stocks

AI Revolutionizes Cardiovascular Clinical Trials: A Leap Towards Cheaper, Faster Drug Development

November 13, 2025

San Francisco, CA – November 13, 2025 – Artificial Intelligence (AI) has achieved a pivotal breakthrough in the medical field, successfully adjudicating clinical events in cardiovascular trials. This...

Via TokenRing AI

Topics Artificial Intelligence

3 Inflated Stocks with Warning Signs

November 12, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

Nvidia's AI Reign: A $5 Trillion Bellwether Shaping Wall Street's Fortunes

November 11, 2025

Nvidia's (NASDAQ: NVDA) recent stock performance has been a whirlwind of soaring highs and sharp corrections, acting as a potent barometer for the broader Wall Street landscape as of November 11, 2025....

Via MarketMinute

Topics Artificial Intelligence Economy Law Enforcement

3 Cash-Producing Stocks We Approach with Caution

November 10, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility

November 07, 2025

Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Q3 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

November 06, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its...

Via StockStory

IQVIA’s Q3 Earnings Call: Our Top 5 Analyst Questions

November 04, 2025

IQVIA's third quarter results reflected stable operational execution, with revenue and profit slightly ahead of Wall Street expectations. Management identified robust free cash flow generation and a...

Via StockStory

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.